These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
474 related items for PubMed ID: 28923422
1. A novel measles outbreak control strategy in the Netherlands in 2013-2014 using a national electronic immunization register: A study of early MMR uptake and its determinants. Nic Lochlainn LM, Woudenberg T, van Lier A, Zonnenberg I, Philippi M, de Melker HE, Hahné SJM. Vaccine; 2017 Oct 13; 35(43):5828-5834. PubMed ID: 28923422 [Abstract] [Full Text] [Related]
2. Tolerability of Early Measles-Mumps-Rubella Vaccination in Infants Aged 6-14 Months During a Measles Outbreak in The Netherlands in 2013-2014. van der Maas NA, Woudenberg T, Hahné SJ, de Melker HE. J Infect Dis; 2016 May 01; 213(9):1466-71. PubMed ID: 26690343 [Abstract] [Full Text] [Related]
3. Increased measles-mumps-rubella (MMR) vaccine uptake in the context of a targeted immunisation campaign during a measles outbreak in a vaccine-reluctant community in England. Le Menach A, Boxall N, Amirthalingam G, Maddock L, Balasegaram S, Mindlin M. Vaccine; 2014 Feb 26; 32(10):1147-52. PubMed ID: 24440207 [Abstract] [Full Text] [Related]
4. Effectiveness of Early Measles, Mumps, and Rubella Vaccination Among 6-14-Month-Old Infants During an Epidemic in the Netherlands: An Observational Cohort Study. Woudenberg T, van der Maas NAT, Knol MJ, de Melker H, van Binnendijk RS, Hahné SJM. J Infect Dis; 2017 Apr 15; 215(8):1181-1187. PubMed ID: 28368471 [Abstract] [Full Text] [Related]
5. Determinants of European parents' decision on the vaccination of their children against measles, mumps and rubella: A systematic review and meta-analysis. Tabacchi G, Costantino C, Napoli G, Marchese V, Cracchiolo M, Casuccio A, Vitale F, The Esculapio Working Group. Hum Vaccin Immunother; 2016 Jul 02; 12(7):1909-23. PubMed ID: 27163657 [Abstract] [Full Text] [Related]
6. Determinants of students' willingness to accept a measles-mumps-rubella booster vaccination during a mumps outbreak: a cross-sectional study. Donkers HW, Hautvast JL, Akkermans RP, Swaan CM, Ruijs WL, Hulscher ME. BMC Public Health; 2015 Jun 20; 15():575. PubMed ID: 26092263 [Abstract] [Full Text] [Related]
13. [Economic evaluation on different two-dose-vaccination-strategies related to Measles, Mumps and Rubella Combined Attenuated Live Vaccine]. He HQ, Zhang B, Yan R, Li Q, Fu J, Tang XW, Zhou Y, Deng X, Xie SY. Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Aug 10; 37(8):1121-6. PubMed ID: 27539345 [Abstract] [Full Text] [Related]
16. Seroprevalence of antibodies to measles, mumps, and rubella, and serologic responses after vaccination among human immunodeficiency virus (HIV)-1 infected adults in Northern Thailand. Chaiwarith R, Praparattanapan J, Nuket K, Kotarathitithum W, Supparatpinyo K. BMC Infect Dis; 2016 Apr 30; 16():190. PubMed ID: 27138005 [Abstract] [Full Text] [Related]
17. Ethnicity as a correlate of the uptake of the first dose of mumps, measles and rubella vaccine. Mixer RE, Jamrozik K, Newsom D. J Epidemiol Community Health; 2007 Sep 30; 61(9):797-801. PubMed ID: 17699534 [Abstract] [Full Text] [Related]